Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2025-04-16 Annual Report
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
2024 Annual Report
Annual Report Classification · 100% confidence The document is clearly identified as the '2024 Annual Report' for SSY Group Limited. It contains comprehensive sections including the Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, and full Consolidated Financial Statements (Profit or Loss, Financial Position, Cash Flow, etc.). It is a full-year reporting document, not an announcement or a summary, fitting the definition of a 10-K (Annual Report). FY 2024
2025-04-16 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 75% confidence The document is a corporate announcement by SSY Group Limited regarding the regulatory approval of its product Felodipine and contains no financial statements, voting results, capital changes, or report publication. It is a voluntary business development update, which does not fit any specialized category (e.g., earnings release, M&A, director dealings). Therefore, it falls under the general “Regulatory Filings” fallback category (RNS).
2025-04-10 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 75% confidence The document is a voluntary corporate announcement by SSY Group Limited providing an update on product development (approval for Phase I trial specifications). It does not contain financial results, governance changes, capital transactions, or other specific report content, nor does it announce the publication of a separate report. Therefore, it is best categorized as a miscellaneous regulatory announcement under the fallback category “Regulatory Filings (RNS).”
2025-04-03 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a formal regulatory disclosure under HKEX Listing Rules (form FF305 “Next Day Disclosure Return”) recording changes in issued shares and detailed share repurchase activity (on-market buyback of 2,800,000 shares, treasury share movements, confirmations, etc.). This constitutes a report of the company buying back its own shares rather than an announcement of a new report, earnings, or board changes. Therefore, it falls under “Transaction in Own Shares” (POS).
2025-04-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 75% confidence The document is titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities” and is clearly a standardized HKEX form (FF301) showing detailed monthly movements in share capital, issued shares, options, and confirmations under listing rule 13.25C/17.27C. It is not an AGM presentation, earnings release, annual or interim report, nor a specific announcement of a dividend, M&A, or director dealing. Instead, it is a periodic regulatory submission required by the exchange. Therefore, it falls under the general “Regulatory Filings” category (RNS).
2025-03-31 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 75% confidence The document is a voluntary corporate announcement by a listed company on HKEX regarding product development approvals, with no financial statements, shareholder votes, or changes in capital structure. It is not an AGM or annual/interim report, nor a dividend notice or share transaction. It is a general regulatory announcement under HKEX listing rules and thus falls under the fallback category of Regulatory Filings (RNS).
2025-03-31 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.